Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / About EDRN / Photographs

Photographs

Photographs of various people working with EDRN.
Image Dean Brenner
Dean E. Brenner, M.D. 2150 Cancer and Geriatrics Center University of Michigan Medical Center 1500 E. Hospital Drive Ann Arbor, MI 48109-0930 Tel: +1 (734)647-1417 Fax: +1 (734)647-9817
Image Michael Tainsky
Michael A. Tainsky, Ph.D. Professor Director, Program in Molecular Biology and Human Genetics Karmanos Cancer Institute Wayne State University 110 East Warren Avenue Detroit, MI 48201 PHONE: 313-833-0715 ext. 2641 FAX: 313-832-7294
Image Arul Chinnaiyan
University of Michigan Department of Pathology M5226 Med Sci I 1301 Catherine Road Ann Arbor, MI 48109-0602 Ph: (734) 647-8153 Fx: (734) 936-7361
Image Samir Hanash
Photograph of Dr Samir Hanash
Image Paul Engstrom
Paul Engstrom, Fox Chase Cancer Center
Image David Fishman
David Fishman, Gynecologic Oncology New York University School of Medicine 550 First Avenue NBV 9N20 New York, NY 10016
Image Jeffrey Marks
Jeffrey Marks at Duke University
Image Martin Sanda
Associate Professor of Surgery-Urology, Harvard Medical School Director, Prostate Care Center Beth Israel-Deaconess Medical Center 330 Brookline Ave Boston, MA 02215
Image David Chia
David Chia at UCLA.
Image Anna Loshkin
Anna E. Lokshin, PhD Assistant Professor of Medicine University of Pittsburgh University of Pittsburgh Cancer Institute Director, Luminex Core Facility Hillman Cancer Center 5117 Centre Ave. Pittsburgh, PA 15213
Image O.J. Semmes
Virginia Prostate Center Eastern Virginia Medical School
Image Alvin Liu
It's Dr Alvin Liu. A team photo is also available.
Image Stephen J. Meltzer
Professor of Medicine (Gastroenterology), Pathology, and Pharmacology Staff Physician, Baltimore VA Maryland Health Care Systems Director, GI Cancer Program University of Maryland School of Medicine 22 S. Greene St., Rm. N3W62 Baltimore, MD 21201 410-706-3375 smeltzer@medicine.umaryland.edu
William Rom
"See the photograph on the NYU web site. Yours, Dr. Rom."
Image Dr Sanford Stass
Dr Sanford Stass of Univ of Maryland.
New Funding Opportunity: Biomarker Development Laboratories for the Early Detection Network: Applications Due May 23

Update: Pre-application webinar information now available.

The National Cancer Institute's Division of Cancer Prevention has released a new funding opportunity to solicit organ-specific applications for Biomarker Developmental Laboratories (BDLs), one of the four scientific units of the recently funded Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. BDLs are responsible for the discovery, development, characterization, and testing of new, or the refinement of existing, biomarkers and biomarker assays for risk assessment, detection, and molecular diagnosis and prognosis of cancers.

The existing BDLs are primarily focused on ovary and gastrointestinal cancers. The proposed BDLs (to be supported under this funding opportunity) should be focused on one or more of the following cancers: breast, prostate and other genitourinary organs, or lung. In addition, cancers with rapidly rising incidence rates, e.g., endometrial, hepatocellular, kidney, thyroid, oropharyngeal cancers, and/or cancers with unique etiology, e.g., mesothelioma, will be considered.

The newly funded units of the Early Detection Research Network will be announced later in April. Successful applicants have already been notified. Those researchers who were not successful during the last round of applications are encouraged to apply to this opportunity.